scispace - formally typeset
S

Stephen C. Pak

Researcher at Washington University in St. Louis

Publications -  71
Citations -  7712

Stephen C. Pak is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Serpin & Caenorhabditis elegans. The author has an hindex of 27, co-authored 63 publications receiving 6933 citations. Previous affiliations of Stephen C. Pak include Boston Children's Hospital & Icahn School of Medicine at Mount Sinai.

Papers
More filters
Patent

Methods of treating disorders associated with protein aggregation

TL;DR: In this paper, the authors present methods of treatment of clinical disorders associated with protein aggregation comprising administering, to a subject, an effective amount of an anti-protein aggregate (APA) compound selected from the group consisting of pimozide, fluphenazine (e.g., fluphensazine hydrochloride), tamoxifen, tamoxifyen citrate, taxol, cantharidin, canthyodorin, and taxol salts thereof and their structurally related compounds.

Chinese hamster ovary cells produce sufficient recombinant insulin-like growth factor I to support growth in serum-free medium

TL;DR: This work constructed an IGF-I heterologous gene driven by the cytomegalovirus promoter, introduced it into Chinese Hamster Ovary cells, and examined the growth characteristics of Insulin-like growth factor I-expressing clonal cells in the absence of the exogenous factor.
Posted ContentDOI

Quantitative Assessment Of Cell Fate Decision Between Autophagy And Apoptosis

TL;DR: A computational model of coupled apoptosis and autophagy is built here to study the systems-level dynamics of the underlying signaling network and identified Ca2+/calmodulin-dependent kinase kinase β (CaMKKβ) as a determinant of the opposite roles of cytoplasmic Ca2+.
Journal ArticleDOI

SERPINB3 (SCCA1) inhibits cathepsin L and lysoptosis, protecting cervical cancer cells from chemoradiation

TL;DR: The endogenous lysosomal cysteine protease inhibitor SERPINB3 (squamous cell carcinoma antigen 1, SCCA1) is elevated in patients with cervical cancer and other malignancies as discussed by the authors .
Journal ArticleDOI

Erratum: De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia (The American Journal of Human Genetics (2019) 105(2) (413–424), (S0002929719302393), (10.1016/j.ajhg.2019.06.014))

Oguz Kanca, +267 more
TL;DR: (The American Journal of Human Genetics 105, 413–424; August 1, 2019)